The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Mu Agonist Opioids and Kappa Opioids | Download Table
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
κ-opioid receptor - Wikipedia
Innovation – Cara Therapeutics
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back